Cleared Traditional

MMC AMPLIFIER (K943673) - FDA 510(k) Clearance

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K943673 · Melville Software , Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1994
Decision
92d
Days
Class 2
Risk

K943673 is an FDA 510(k) clearance for the MMC AMPLIFIER. Classified as Amplifier, Physiological Signal (product code GWL), Class II - Special Controls.

Submitted by Melville Software , Ltd. (Ottawa, Ontario, CA). The FDA issued a Cleared decision on October 26, 1994 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1835 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Melville Software , Ltd. devices

Submission Details

510(k) Number K943673 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 1994
Decision Date October 26, 1994
Days to Decision 92 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 148d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GWL Amplifier, Physiological Signal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1835
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWL Amplifier, Physiological Signal

All 52
Devices cleared under the same product code (GWL) and FDA review panel - the closest regulatory comparables to K943673.
Delphi Amplifier
K243746 · Quantalx Neroscience · Mar 2025
NExT Station
K242832 · Eb Neuro S.P.A. · Dec 2024
DreamClear
K240646 · Somnomed Technologies Inc., Doing Business AS Remware · Sep 2024
BE Plus PRO, Neurotravel LIGHT
K242305 · Eb Neuro S.P.A. · Sep 2024
X-trodes System M
K232210 · X-Trodes · Feb 2024
Vlab
K230148 · Dormotech Medical, Ltd. · Oct 2023